Haemonetics Corporation Proceeds from Sale of Real Estate
Haemonetics Corporation (HAE) reported Proceeds from Sale of Real Estate of $15.00 million for the 12-month period ending 2021-04-03, per its 10-K filed 2022-05-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfRealEstate · last filed 2022-05-25
- Haemonetics Corporation proceeds from sale of real estate for fiscal 2021 was $15.00M, a 0.00% change from fiscal 2020.
- Haemonetics Corporation proceeds from sale of real estate for fiscal 2020 was $15.00M.
| Period end | Proceeds from Sale of Real Estate 12 month |
|---|---|
| 2021-04-03 | $15.00M 10-K · filed 2022-05-25 |
| 2020-03-28 | $15.00M 10-K · filed 2021-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |